| Low vitamin D levels are associated with increased rejection and infections after lung transplantation EM Lowery, B Bemiss, T Cascino, RA Durazo-Arvizu, SM Forsythe, C Alex, ... The Journal of heart and lung transplantation 31 (7), 700-707, 2012 | 82 | 2012 |
| Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the CleanUP-IPF randomized clinical trial FJ Martinez, E Yow, KR Flaherty, LD Snyder, MT Durheim, SR Wisniewski, ... Jama 325 (18), 1841-1851, 2021 | 68 | 2021 |
| Antibody-mediated rejection in lung transplantation HS Kulkarni, BC Bemiss, RR Hachem Current transplantation reports 2, 316-323, 2015 | 54 | 2015 |
| 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic … SR Johnson, EJ Bernstein, MB Bolster, JH Chung, SK Danoff, MD George, ... Arthritis & rheumatology 76 (8), 1182-1200, 2024 | 48 | 2024 |
| The impact of pre-transplant allosensitization on outcomes after lung transplantation JP Bosanquet, CA Witt, BC Bemiss, DE Byers, RD Yusen, AG Patterson, ... The Journal of Heart and Lung Transplantation 34 (11), 1415-1422, 2015 | 48 | 2015 |
| 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with … SR Johnson, EJ Bernstein, MB Bolster, JH Chung, SK Danoff, MD George, ... Arthritis Care & Research 76 (8), 1070-1082, 2024 | 35 | 2024 |
| Impact of delayed chest closure on surgical site infection after lung transplantation PR Aguilar, BC Bemiss, C Witt, DE Byers, D Kreisel, V Puri, B Meyers, ... The Annals of Thoracic Surgery 104 (4), 1208-1214, 2017 | 21 | 2017 |
| Chronic lung allograft dysfunction following lung transplantation: challenges and solutions BC Bemiss, CA Witt Transplant Research and Risk Management, 87-97, 2014 | 5 | 2014 |
| Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation R Shaw, AR Haque, T Luu, TE O’Connor, A Hamidi, J Fitzsimons, B Varda, ... Frontiers in Oncology 13, 1146002, 2023 | 3 | 2023 |
| Use of Nintedanib and Pirfenidone in Non–Idiopathic Pulmonary Fibrosis Lung Disease K Warrior, PA Chung, M Reid, BC Bemiss American journal of respiratory and critical care medicine 204 (1), 92-94, 2021 | 3 | 2021 |
| CLCA1 peptide levels as accurate biomarkers of the type 2 immune pathway and disease severity in asthma DE Byers, YG Alevy, J Tucker, BC Bemiss, R Grainger, TJ Brett, M Castro, ... D92. INFLAMMATORY PATHWAYS IN ASTHMA AND COPD, A6058-A6058, 2015 | 3 | 2015 |
| Desensitization therapy before lung transplantation PR Aguilar, CA Witt, BC Bemiss, AS Krupnick, D Kreisel, RD Yusen, ... The Journal of Heart and Lung Transplantation 35 (4), S237, 2016 | 2 | 2016 |
| Airway associated inflammation in post-transplant cystic fibrosis patients as a predictor of chronic lung allograft dysfunction (CLAD) T Patel, B Bemiss, E Panah, T Chaiprasit, A McHenry, G Venkataraman, ... Journal of Clinical Pathology, 2025 | | 2025 |
| Renal Sparing Immunosuppression Regimens in Lung Transplant Recipients H Kleiboeker, M Mahesri, M Carns, S Mohsin, C Myers, A Arunachalam, ... The Journal of Heart and Lung Transplantation 43 (4), S305, 2024 | | 2024 |
| Machine learning analysis of the UNOS database fails to predict lung transplant outcomes L Luo, M MoĹźejko, N Markov, A Peltekian, S Mohsin, M Carns, P Cooper, ... medRxiv, 2024.10. 19.24315817, 2024 | | 2024 |
| Multicenter analysis of immunosuppressive medications on the subsequent risk of malignancy in solid organ transplant recipients R Shaw, AR Haque, J Fitzsimons, A Hamidi, TE O’Connor, GW Roloff, ... medRxiv, 2022.12. 02.22283027, 2022 | | 2022 |
| Lung Transplantation for Hermansky-Pudlak Syndrome: A Single-Center Experience N Ramachandra, KS Lal, K Warrior, JP Schwartz, ZM Abdelsattar, ... A23. CASE REPORTS IN ILD AND LUNG TRANSPLANTATION, A1099-A1099, 2022 | | 2022 |
| Use of Tacrolimus to Treat Anti-Synthetase Syndrome-Associated Interstitial Lung Disease K Warrior, B Bemiss A37. ILD THERAPY I, A1527-A1527, 2020 | | 2020 |
| Mepolizumab as Treatment for Chronic Eosinophilic Pneumonia A Saeed, M Reid, PA Chung, K Warrior, B Bemiss A33. ASTHMA ALLERGY AND IMMUNOLOGY CASES, A1356-A1356, 2020 | | 2020 |
| Change in Diagnosis at Interstitial Lung Disease Multi-Disciplinary Discussion K Warrior, PA Chung, DF Dilling, V Ananthanarayanan, GP Camren, ... A102. ILD DIAGNOSIS AND MONITORING, A2563-A2563, 2020 | | 2020 |
